{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2008-N-0039\" sorted by posted_date descending", "rows": [["FDA-2008-N-0039-0098", "FDA", "FDA-2008-N-0039", "Supplement Abbreviated New Animal Drug Application; Flunazine, (flunixin meglumine), Injectable Solution, Horses and Cattle - Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2009-02-12T05:00:00Z", 2009, 2, null, null, "2014-01-08T14:19:17Z", null, 0, 0, "09000064808548d1"], ["FDA-2008-N-0039-0097", "FDA", "FDA-2008-N-0039", "Implantation or Injectable Dosage Form New Animal Drugs: Flunixin - Final Rule", "Notice", "Notice of Final Rule", "2009-02-12T05:00:00Z", 2009, 2, null, null, "2014-01-08T14:17:02Z", "E9-02941", 0, 0, "09000064808545a3"], ["FDA-2008-N-0039-0096", "FDA", "FDA-2008-N-0039", "Supplemental Abbreviated New Animal Drug Application - PHOENECTIN Paste 1.87%, (ivermectin), Oral Paste-Horses - Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2009-02-10T05:00:00Z", 2009, 2, null, null, "2014-01-08T14:16:01Z", null, 0, 0, "090000648084fa4c"], ["FDA-2008-N-0039-0095", "FDA", "FDA-2008-N-0039", "Oral Dosage Form New Animal Drugs: Ivermectin Paste - Final Rule", "Rule", "Final Rule", "2009-02-10T05:00:00Z", 2009, 2, "2009-02-10T05:00:00Z", null, "2014-01-08T14:11:50Z", "E9-02749", 0, 0, "090000648084f677"], ["FDA-2008-N-0039-0094", "FDA", "FDA-2008-N-0039", "Oral Dosage Form New Animal Drugs: Phenylbutazone Tablets and Boluses", "Rule", "Final Rule", "2009-01-12T05:00:00Z", 2009, 1, "2009-01-12T05:00:00Z", null, "2013-07-09T19:32:23Z", "E9-00265", 0, 0, "090000648081b72e"], ["FDA-2008-N-0039-0093", "FDA", "FDA-2008-N-0039", "New Animal Drugs for Use in Animal Feeds; Tiamulin", "Rule", "Final Rule", "2009-01-02T05:00:00Z", 2009, 1, "2009-01-02T05:00:00Z", null, "2013-07-09T19:38:10Z", "E8-31128", 0, 0, "090000648080c33b"], ["FDA-2008-N-0039-0092", "FDA", "FDA-2008-N-0039", "Freedom of Information Summary - Original Abbreviated New Drug Application - ANADA 200-459", "Supporting & Related Material", "Freedom of Information Summary", "2008-12-29T05:00:00Z", 2008, 12, null, null, "2013-07-09T18:51:04Z", null, 0, 0, "0900006480805f78"], ["FDA-2008-N-0039-0091", "FDA", "FDA-2008-N-0039", "Ophthalmic and Topical Dosage Form New Animal Drugs; Triamcinolone Cream", "Rule", "Final Rule", "2008-12-29T05:00:00Z", 2008, 12, "2008-12-29T05:00:00Z", null, "2013-07-09T18:48:19Z", "E8-30694", 0, 0, "0900006480805eeb"], ["FDA-2008-N-0039-0090", "FDA", "FDA-2008-N-0039", "Freedom of Information Summary - NADA 013-076 - TYLAN Soluble Tylosin tartrate Soluble powder Swine", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2008-12-18T05:00:00Z", 2008, 12, null, null, "2008-12-20T16:29:53Z", null, 0, 0, "09000064807e0877"], ["FDA-2008-N-0039-0089", "FDA", "FDA-2008-N-0039", "Freedom of Information Summary - NADA 012-491 - TYLAN 40 and TYLAN 100 Tylosin phosphate", "Supporting & Related Material", "Freedom of Information Summary", "2008-12-18T05:00:00Z", 2008, 12, null, null, "2013-07-11T14:46:49Z", null, 0, 0, "09000064807e084d"], ["FDA-2008-N-0039-0088", "FDA", "FDA-2008-N-0039", "New Animal Drugs; Tylosin", "Notice", "Notice of Final Rule", "2008-12-18T05:00:00Z", 2008, 12, null, null, "2013-07-11T14:42:33Z", "E8-29861", 0, 0, "09000064807e0691"], ["FDA-2008-N-0039-0086", "FDA", "FDA-2008-N-0039", "New Animal Drugs for Use in Animal Feeds; Ractopamine", "Notice", "Notice of Final Rule", "2008-12-11T05:00:00Z", 2008, 12, null, null, "2013-07-09T20:00:14Z", "E8-29177", 0, 0, "09000064807d7057"], ["FDA-2008-N-0039-0087", "FDA", "FDA-2008-N-0039", "Freedom of Information (FOI) Summary - Optaflexx (ractopamine hydrochloride), Rumensin (monensin sodium) Tylan (tylosin phosphate) and HEIFERMAX 500 (melengestrol acetate)", "Supporting & Related Material", "Freedom of Information Summary", "2008-12-11T05:00:00Z", 2008, 12, null, null, "2013-07-09T20:02:52Z", null, 0, 0, "09000064807d7224"], ["FDA-2008-N-0039-0083", "FDA", "FDA-2008-N-0039", "Freedom of Information Summary - Original New Animal Drug Application - NADA 141-290 - TOPMAX 9 (Ractopamine Hydrochloride) Type A Medicated Article Finishing Turkeys", "Supporting & Related Material", "Freedom of Information Summary", "2008-12-01T05:00:00Z", 2008, 12, null, null, "2013-07-10T16:18:47Z", null, 0, 0, "09000064807c743a"], ["FDA-2008-N-0039-0084", "FDA", "FDA-2008-N-0039", "Environmental Assessment For the Use of Topmax\u00ae in the Feed of Turkeys", "Supporting & Related Material", "Environmental Assessment", "2008-12-01T05:00:00Z", 2008, 12, null, null, "2013-07-10T16:22:43Z", null, 0, 0, "09000064807c7469"], ["FDA-2008-N-0039-0082", "FDA", "FDA-2008-N-0039", "New Animal Drugs; Ractopamine", "Rule", "Final Rule", "2008-12-01T05:00:00Z", 2008, 12, "2008-12-01T05:00:00Z", null, "2013-07-10T16:15:59Z", "E8-28384", 0, 0, "09000064807c7111"], ["FDA-2008-N-0039-0085", "FDA", "FDA-2008-N-0039", "Finding of No Significant Impact - Topmax\u00ae (Ractopamine HCl) in the Feed of Turkeys", "Supporting & Related Material", "Finding of no Significant Impact", "2008-12-01T05:00:00Z", 2008, 12, null, null, "2013-07-10T16:25:00Z", null, 0, 0, "09000064807c7491"], ["FDA-2008-N-0039-0081", "FDA", "FDA-2008-N-0039", "Oral Dosage Form New Animal Drugs; Amprolium; Correction", "Rule", "Correction", "2008-11-20T05:00:00Z", 2008, 11, "2008-11-20T05:00:00Z", null, "2013-07-11T14:19:15Z", "E8-27646", 0, 0, "09000064807b36b5"], ["FDA-2008-N-0039-0079", "FDA", "FDA-2008-N-0039", "Approval of Original Abbreviated New Animal Drug Application; Phenylbutazone Tablets", "Notice", "Notice of Approval", "2008-11-12T05:00:00Z", 2008, 11, null, null, "2013-07-09T19:53:18Z", "E8-26793", 0, 0, "09000064807a4da6"], ["FDA-2008-N-0039-0080", "FDA", "FDA-2008-N-0039", "Freedom of Information (FOI) Summary - FOIS", "Supporting & Related Material", "Freedom of Information Summary", "2008-11-12T05:00:00Z", 2008, 11, null, null, "2013-07-09T19:57:19Z", null, 0, 0, "09000064807a4f83"], ["FDA-2008-N-0039-0078", "FDA", "FDA-2008-N-0039", "Freedom of Information Summary - FOIS", "Supporting & Related Material", "Freedom of Information Summary", "2008-10-31T04:00:00Z", 2008, 10, null, null, "2013-07-10T18:59:33Z", null, 0, 0, "090000648078785b"], ["FDA-2008-N-0039-0077", "FDA", "FDA-2008-N-0039", "Oral Dosage Form New Animal Drugs; Firocoxib Tablets", "Rule", "Final Rule", "2008-10-31T04:00:00Z", 2008, 10, null, null, "2013-07-10T18:54:17Z", "E8-26020", 0, 0, "090000648078769c"], ["FDA-2008-N-0039-0071", "FDA", "FDA-2008-N-0039", "Implantation or Injectable Dosage Form New Animal Drugs; Tulathromycin", "Rule", "Final Rule", "2008-10-08T04:00:00Z", 2008, 10, "2008-10-08T04:00:00Z", null, "2013-07-10T18:24:50Z", "E8-23832", 0, 0, "090000648073e0bc"], ["FDA-2008-N-0039-0075", "FDA", "FDA-2008-N-0039", "Implantation or Injectable Dosage Form New Animal Drugs; Ceftiofur Crystalline Free Acid", "Rule", "Final Rule", "2008-10-08T04:00:00Z", 2008, 10, "2008-10-08T04:00:00Z", null, "2013-07-10T19:01:42Z", "E8-23830", 0, 0, "090000648073e103"], ["FDA-2008-N-0039-0074", "FDA", "FDA-2008-N-0039", "Safe-Guard (Fenbendazole) - Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2008-10-08T04:00:00Z", 2008, 10, null, null, "2013-07-10T20:13:33Z", null, 0, 0, "090000648073e4e2"], ["FDA-2008-N-0039-0076", "FDA", "FDA-2008-N-0039", "Excede (Ceftiofur Crystalline Free Acid) Sterile Suspension - Freedom of Information Summary", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2008-10-08T04:00:00Z", 2008, 10, null, null, "2013-07-10T19:04:11Z", null, 0, 0, "090000648073e577"], ["FDA-2008-N-0039-0072", "FDA", "FDA-2008-N-0039", "Draxxin (Tulathromycin) Injectable Solution - Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2008-10-08T04:00:00Z", 2008, 10, null, null, "2013-07-10T18:28:38Z", null, 0, 0, "090000648073e476"], ["FDA-2008-N-0039-0073", "FDA", "FDA-2008-N-0039", "New Animal Drugs for Use in Animal Feeds; Fenbendazole", "Rule", "Final Rule", "2008-10-08T04:00:00Z", 2008, 10, "2008-10-08T04:00:00Z", null, "2013-07-10T20:10:36Z", "E8-23845", 0, 0, "090000648073e0ff"], ["FDA-2008-N-0039-0070", "FDA", "FDA-2008-N-0039", "Oral Dosage Form New Animal Drugs; Sulfadiazine/Pyrimethamine Suspension", "Rule", "Final Rule", "2008-09-17T04:00:00Z", 2008, 9, "2008-09-17T04:00:00Z", null, "2013-07-10T18:41:20Z", "E8-21625", 0, 0, "090000648070a75b"], ["FDA-2008-N-0039-0068", "FDA", "FDA-2008-N-0039", "Chloramine-T for Control of Bacterial Gill Disease in Freshwater- Reared Salmonids; Availability of Data", "Notice", "Notice of Availability", "2008-08-21T04:00:00Z", 2008, 8, null, null, "2013-07-11T14:27:19Z", "E8-19299", 0, 0, "09000064806d1357"], ["FDA-2008-N-0039-0069", "FDA", "FDA-2008-N-0039", "Freedom of Information Summary Chloramine - T Soluble Powder for Immersion Freshwater - reared salmonids - FOIS", "Supporting & Related Material", "Freedom of Information Summary", "2008-08-21T04:00:00Z", 2008, 8, null, null, "2013-07-11T14:29:57Z", null, 0, 0, "09000064806d152a"], ["FDA-2008-N-0039-0065", "FDA", "FDA-2008-N-0039", "Freedom of Information Summary [New Animal Drugs For Use in Animal Feeds; Oxytetracycline - NADA 38-439] - FOIS", "Supporting & Related Material", "Freedom of Information Summary", "2008-08-07T04:00:00Z", 2008, 8, null, null, "2013-07-11T13:49:07Z", null, 0, 0, "09000064806b4494"], ["FDA-2008-N-0039-0064", "FDA", "FDA-2008-N-0039", "New Animal Drugs For Use in Animal Feeds; Oxytetracycline", "Rule", "Final Rule", "2008-08-07T04:00:00Z", 2008, 8, null, null, "2013-07-11T13:44:20Z", "E8-18129", 0, 0, "09000064806b4074"], ["FDA-2008-N-0039-0067", "FDA", "FDA-2008-N-0039", "See FDA-2008-N-0039-0066.1", "Supporting & Related Material", "Environmental Assessment", "2008-08-07T04:00:00Z", 2008, 8, null, null, "2013-07-11T13:56:58Z", null, 0, 0, "09000064806b46f9"], ["FDA-2008-N-0039-0066", "FDA", "FDA-2008-N-0039", "Finding of No Significant Impact [New Animal Drugs For Use in Animal Feeds; Oxytetracycline - NADA 38-439]- FONSI", "Supporting & Related Material", "Freedom of Information Summary", "2008-08-07T04:00:00Z", 2008, 8, null, null, "2013-07-11T13:53:14Z", null, 0, 0, "09000064806b44c9"], ["FDA-2008-N-0039-0060", "FDA", "FDA-2008-N-0039", "Oral Dosage Form New Animal Drugs; Amprolium", "Rule", "Final Rule", "2008-08-06T04:00:00Z", 2008, 8, "2008-08-06T04:00:00Z", null, "2013-07-11T14:22:57Z", "E8-18093", 0, 0, "09000064806b15a2"], ["FDA-2008-N-0039-0063", "FDA", "FDA-2008-N-0039", "Ceftiofur Hydrochloride (Excenel Rtu Ez) Sterile Suspension - Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2008-08-06T04:00:00Z", 2008, 8, null, null, "2013-07-10T16:31:44Z", null, 0, 0, "09000064806b1a9b"], ["FDA-2008-N-0039-0061", "FDA", "FDA-2008-N-0039", "Oral Dosage Form New Animal Drugs; Oxfendazole Suspension", "Rule", "Final Rule", "2008-08-06T04:00:00Z", 2008, 8, "2008-08-06T04:00:00Z", null, "2013-07-10T19:50:02Z", "E8-18092", 0, 0, "09000064806b161e"], ["FDA-2008-N-0039-0062", "FDA", "FDA-2008-N-0039", "Implantation or Injectable Dosage Form New Animal Drugs; Ceftiofur Hydrochloride", "Rule", "Final Rule", "2008-08-06T04:00:00Z", 2008, 8, "2008-08-06T04:00:00Z", null, "2013-07-10T16:28:17Z", "E8-18094", 0, 0, "09000064806b166e"], ["FDA-2008-N-0039-0059", "FDA", "FDA-2008-N-0039", "Oral Dosage Form New Animal Drugs; Sulfachlorpyridazine Powder", "Rule", "Final Rule", "2008-06-24T04:00:00Z", 2008, 6, "2008-06-24T04:00:00Z", null, "2013-07-11T14:16:03Z", "E8-14291", 0, 0, "0900006480639a99"], ["FDA-2008-N-0039-0058", "FDA", "FDA-2008-N-0039", "New Animal Drugs; Change of Sponsors Drug Labeler Code", "Rule", "Final Rule", "2008-06-23T04:00:00Z", 2008, 6, "2008-06-23T04:00:00Z", null, "2013-07-11T14:33:23Z", "E8-14149", 0, 0, "090000648063712a"], ["FDA-2008-N-0039-0055", "FDA", "FDA-2008-N-0039", "New Animal Drugs For Use in Animal Feeds; Tylosin", "Rule", "Final Rule", "2008-06-17T04:00:00Z", 2008, 6, "2008-06-17T04:00:00Z", null, "2013-07-10T18:02:55Z", "E8-13606", 0, 0, "090000648062a67e"], ["FDA-2008-N-0039-0056", "FDA", "FDA-2008-N-0039", "Oral Dosage Form New Animal Drugs; Ivermectin Paste", "Rule", "Final Rule", "2008-06-17T04:00:00Z", 2008, 6, "2008-06-17T04:00:00Z", null, "2013-07-10T15:21:43Z", "E8-13607", 0, 0, "090000648062a642"], ["FDA-2008-N-0039-0057", "FDA", "FDA-2008-N-0039", "Freedom of Information Summary-Supplemental Abbreviated New Animal Drug Application-ANADA 200-326-BIMECTIN Paste 1.87% (ivermectin)-Oral Paste for use in Horses", "Supporting & Related Material", "Freedom of Information Summary", "2008-06-17T04:00:00Z", 2008, 6, null, null, "2013-07-10T15:26:02Z", null, 0, 0, "090000648062a871"], ["FDA-2008-N-0039-0053", "FDA", "FDA-2008-N-0039", "Oral Dosage Form New Animal Drugs; Ivermectin, Fenbendazole, and Praziquantel Tablets", "Rule", "Final Rule", "2008-06-13T04:00:00Z", 2008, 6, null, null, "2013-07-10T16:34:56Z", "E8-13354", 0, 0, "0900006480623e54"], ["FDA-2008-N-0039-0054", "FDA", "FDA-2008-N-0039", "Freedom Of Information Summary NADA 141-286 Panacur Plus Chewable Dog Tablets", "Supporting & Related Material", "Freedom of Information Summary", "2008-06-13T04:00:00Z", 2008, 6, null, null, "2013-07-10T16:39:41Z", null, 0, 0, "09000064806240e3"], ["FDA-2008-N-0039-0052", "FDA", "FDA-2008-N-0039", "Freedom Of Information Summary - FOIS Deramaxx Chewable Tablets", "Supporting & Related Material", "Freedom of Information Summary", "2008-06-13T04:00:00Z", 2008, 6, null, null, "2013-07-10T19:10:19Z", null, 0, 0, "090000648062406b"], ["FDA-2008-N-0039-0051", "FDA", "FDA-2008-N-0039", "Oral Dosage Form New Animal Drugs; Deracoxib", "Rule", "Final Rule", "2008-06-13T04:00:00Z", 2008, 6, null, null, "2013-07-10T19:07:16Z", "E8-13353", 0, 0, "0900006480623d7e"], ["FDA-2008-N-0039-0050", "FDA", "FDA-2008-N-0039", "Freedom of Information Summary for Supplemental New Animal Drug Application - NADA 141-189, PROHEART 6 Sustained Release Injectable for Dogs (Moxidectin) Dogs over 6 months of age", "Supporting & Related Material", "Freedom of Information Summary", "2008-06-09T04:00:00Z", 2008, 6, null, null, "2013-07-10T19:18:09Z", null, 0, 0, "090000648061974d"], ["FDA-2008-N-0039-0049", "FDA", "FDA-2008-N-0039", "Notice of Approval of Supplemental New Animal Drug Application; Moxidectin", "Rule", "Approval", "2008-06-09T04:00:00Z", 2008, 6, "2008-06-09T04:00:00Z", null, "2013-07-10T19:13:32Z", "08-01329", 0, 0, "0900006480619532"], ["FDA-2008-N-0039-0047", "FDA", "FDA-2008-N-0039", "Implantation or Injectable Dosage Form New Animal Drugs; Butorphanol", "Rule", "Final Rule", "2008-06-02T04:00:00Z", 2008, 6, "2008-06-02T04:00:00Z", null, "2013-07-10T15:16:42Z", "E8-12160", 0, 0, "090000648060bd12"], ["FDA-2008-N-0039-0048", "FDA", "FDA-2008-N-0039", "Freedom of Information Summary for ANADA 200-332 - BUTORPHIC Injection (butorphanol tartrate)", "Supporting & Related Material", "Freedom of Information Summary", "2008-06-02T04:00:00Z", 2008, 6, null, null, "2013-07-10T15:19:46Z", null, 0, 0, "090000648060bf45"], ["FDA-2008-N-0039-0046", "FDA", "FDA-2008-N-0039", "Cefovecin - Freedom of Information Summary", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2008-05-22T04:00:00Z", 2008, 5, null, null, "2008-05-22T16:53:54Z", null, 0, 0, "09000064805f8d0f"], ["FDA-2008-N-0039-0045", "FDA", "FDA-2008-N-0039", "Implantation or Injectable Dosage Form New Animal Drugs; Cefovecin", "Rule", "Final Rule", "2008-05-22T04:00:00Z", 2008, 5, "2008-05-22T04:00:00Z", null, "2013-07-09T20:04:25Z", "E8-11515", 0, 0, "09000064805f84e3"], ["FDA-2008-N-0039-0044", "FDA", "FDA-2008-N-0039", "FOIS - Freedom of Information Summary", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2008-05-15T04:00:00Z", 2008, 5, null, null, "2008-05-15T12:58:59Z", null, 0, 0, "09000064805c829f"], ["FDA-2008-N-0039-0043", "FDA", "FDA-2008-N-0039", "Implantation or Injectable Dosage Form New Animal Drugs; Flunixin", "Rule", "Final Rule", "2008-05-15T04:00:00Z", 2008, 5, "2008-05-15T04:00:00Z", null, "2013-07-10T15:59:09Z", "E8-10856", 0, 0, "09000064805c7f71"], ["FDA-2008-N-0039-0041", "FDA", "FDA-2008-N-0039", "Certain Other Dosage Form New Animal Drugs; Sevoflurane", "Rule", "Final Rule", "2008-05-07T04:00:00Z", 2008, 5, null, null, "2013-07-09T18:52:23Z", "E8-10153", 0, 0, "090000648054eee0"], ["FDA-2008-N-0039-0042", "FDA", "FDA-2008-N-0039", "Sevoflurane; Freedom of Information Summary", "Rule", "Final Rule", "2008-05-07T04:00:00Z", 2008, 5, "2008-05-07T04:00:00Z", null, "2013-07-09T18:53:51Z", null, 0, 0, "090000648054f250"], ["FDA-2008-N-0039-0040", "FDA", "FDA-2008-N-0039", "New Animal Drugs; Change of Sponsors Name", "Rule", "Final Rule", "2008-04-29T04:00:00Z", 2008, 4, null, null, "2013-07-11T14:34:22Z", "E8-09328", 0, 0, "0900006480539f86"], ["FDA-2008-N-0039-0036", "FDA", "FDA-2008-N-0039", "New Animal Drugs; Enrofloxacin Final Rule", "Rule", "Final Rule", "2008-04-23T04:00:00Z", 2008, 4, null, null, "2013-07-10T19:23:29Z", "E8-08713", 0, 0, "090000648052275b"], ["FDA-2008-N-0039-0038", "FDA", "FDA-2008-N-0039", "Freedom of Information Summary", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2008-04-23T04:00:00Z", 2008, 4, null, null, "2008-04-23T12:36:51Z", null, 0, 0, "0900006480511fc8"], ["FDA-2008-N-0039-0037", "FDA", "FDA-2008-N-0039", "Freedom of Information Summary", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2008-04-23T04:00:00Z", 2008, 4, null, null, "2008-04-23T12:36:50Z", null, 0, 0, "0900006480511f87"], ["FDA-2008-N-0039-0039", "FDA", "FDA-2008-N-0039", "Enrofloxacin Freedom of Information Summary", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2008-04-23T04:00:00Z", 2008, 4, null, null, "2008-04-23T12:36:51Z", null, 0, 0, "0900006480522960"], ["FDA-2008-N-0039-0035", "FDA", "FDA-2008-N-0039", "Implantation or Injectable Dosage Form New Animal Drugs; Insulin", "Rule", "Final Rule", "2008-04-18T04:00:00Z", 2008, 4, null, null, "2013-07-10T18:42:50Z", "E8-08347", 0, 0, "0900006480511b3a"], ["FDA-2008-N-0039-0034", "FDA", "FDA-2008-N-0039", "Implantation or Injectable Dosage Form New Animal Drugs; Florfenicol", "Rule", "Final Rule", "2008-04-18T04:00:00Z", 2008, 4, null, null, "2013-07-10T19:52:36Z", "E8-08346", 0, 0, "0900006480511af1"], ["FDA-2008-N-0039-0033", "FDA", "FDA-2008-N-0039", "FOI Summary for NADA 141-282 ZILMAX plus RUMENSIN plus MGA (Zilpaterol Hydrochloride and Monensin USP and Melengesterol Acetate)", "Supporting & Related Material", "Freedom of Information Summary", "2008-04-10T04:00:00Z", 2008, 4, null, null, "2013-07-10T17:23:56Z", null, 0, 0, "09000064804a369b"], ["FDA-2008-N-0039-0032", "FDA", "FDA-2008-N-0039", "New Animal Drugs For Use in Animal Feed; Zilpaterol", "Rule", "Final Rule", "2008-04-10T04:00:00Z", 2008, 4, null, null, "2013-07-10T17:18:08Z", "E8-07583", 0, 0, "09000064804a32eb"], ["FDA-2008-N-0039-0031", "FDA", "FDA-2008-N-0039", "FOI Summary for ZILMAX plus RUMENSIN plus TYLAN plus MGA, NADA 141-280 (Zilpaterol Hydrochloride and Monensin USP and Tylosin Phosphate and Melengestrol Acetate)", "Supporting & Related Material", "Freedom of Information Summary", "2008-04-08T04:00:00Z", 2008, 4, null, null, "2013-07-10T17:49:51Z", null, 0, 0, "090000648046e774"], ["FDA-2008-N-0039-0030", "FDA", "FDA-2008-N-0039", "New Animal Drugs for Use in Animal Feed; Zilpaterol; Technical Amendment", "Rule", "NFR-Notice of Final Rule", "2008-04-08T04:00:00Z", 2008, 4, "2008-04-08T04:00:00Z", null, "2008-04-11T22:39:13Z", "E8-07307", 0, 0, "090000648046e47e"], ["FDA-2008-N-0039-0029", "FDA", "FDA-2008-N-0039", "Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of NADAs; Technical Amendment", "Rule", "Final Rule", "2008-04-04T04:00:00Z", 2008, 4, "2008-04-04T04:00:00Z", null, "2013-07-11T14:36:14Z", "E8-07103", 0, 0, "0900006480439f88"], ["FDA-2008-N-0039-0026", "FDA", "FDA-2008-N-0039", "Implantation or Injectable Dosage Form New Animal Drugs; Enrofloxacin", "Rule", "Final Rule", "2008-04-02T04:00:00Z", 2008, 4, null, null, "2013-07-10T19:26:20Z", "E8-06706", 0, 0, "0900006480427483"], ["FDA-2008-N-0039-0027", "FDA", "FDA-2008-N-0039", "FOI Summary for Zilpaterol, NADA 141-284m ZILMAX plus MGA (Zipaterol Hydrochloride and Melengestrol Acetatate) Type A Medicated Articles", "Supporting & Related Material", "Freedom of Information Summary", "2008-04-02T04:00:00Z", 2008, 4, null, null, "2013-07-10T17:16:49Z", null, 0, 0, "090000648041496e"], ["FDA-2008-N-0039-0028", "FDA", "FDA-2008-N-0039", "NADA 141-068 Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2008-04-02T04:00:00Z", 2008, 4, null, null, "2013-07-10T19:29:16Z", null, 0, 0, "09000064804276c7"], ["FDA-2008-N-0039-0025", "FDA", "FDA-2008-N-0039", "Implantation or Injectable Dosage Form New Animal Drugs; Penicillin G Benzathine and Penicillin G Procaine Suspension", "Rule", "Final Rule", "2008-03-31T04:00:00Z", 2008, 3, null, null, "2013-07-11T13:26:42Z", "E8-06603", 0, 0, "0900006480414884"], ["FDA-2008-N-0039-0024", "FDA", "FDA-2008-N-0039", "New Animal Drugs For Use in Animal Feed; Zilpaterol", "Rule", "NFR-Notice of Final Rule", "2008-03-31T04:00:00Z", 2008, 3, null, null, "2013-07-10T16:46:30Z", "E8-06601", 0, 0, "0900006480414833"], ["FDA-2008-N-0039-0023", "FDA", "FDA-2008-N-0039", "FOI Summary for Nicarbazin and Bacitracin Methylene Disalycylate NADA 141-279", "Supporting & Related Material", "Freedom of Information Summary", "2008-03-26T04:00:00Z", 2008, 3, null, null, "2013-07-10T17:53:21Z", null, 0, 0, "0900006480409788"], ["FDA-2008-N-0039-0022", "FDA", "FDA-2008-N-0039", "New Animal Drugs for Use in Animal Feeds; Bacitracin Methylene Disalicylate and Nicarbazin", "Rule", "Final Rule", "2008-03-26T04:00:00Z", 2008, 3, null, null, "2013-07-10T17:51:33Z", "E8-06063", 0, 0, "090000648040922b"], ["FDA-2008-N-0039-0021", "FDA", "FDA-2008-N-0039", "Implantation or Injectable Dosage Form New Animal Drugs; Oxytetracycline Solution", "Rule", "Final Rule", "2008-03-20T04:00:00Z", 2008, 3, null, null, "2013-07-10T19:19:30Z", "E8-05598", 0, 0, "0900006480400974"], ["FDA-2008-N-0039-0019", "FDA", "FDA-2008-N-0039", "New Animal Drugs for Use in Animal Feed; Zilpaterol", "Rule", "Final Rule", "2008-03-18T04:00:00Z", 2008, 3, null, null, "2013-07-10T17:55:05Z", "E8-05450", 0, 0, "09000064803fc2e6"], ["FDA-2008-N-0039-0018", "FDA", "FDA-2008-N-0039", "New Animal Drugs; Change of Sponsors Name; Iron Injection; Technical Amendment", "Rule", "Final Rule", "2008-03-18T04:00:00Z", 2008, 3, null, null, "2013-07-11T12:54:27Z", "E8-05452", 0, 0, "09000064803fc3f3"], ["FDA-2008-N-0039-0020", "FDA", "FDA-2008-N-0039", "Freedom of Information Summary-[NADA 141-278], ZILMAX plus RUMENSIN (Zilpaterol Hydrochloride and Monensin USP)", "Supporting & Related Material", "Freedom of Information Summary", "2008-03-18T04:00:00Z", 2008, 3, null, null, "2013-07-10T17:57:36Z", null, 0, 0, "09000064803fc63a"], ["FDA-2008-N-0039-0017", "FDA", "FDA-2008-N-0039", "Implantation or Injectable Dosage Form New Animal Drugs; Penicillin G Procaine Aqueous Suspension", "Rule", "Final Rule", "2008-03-17T04:00:00Z", 2008, 3, "2008-03-17T04:00:00Z", null, "2013-07-11T13:42:23Z", "E8-05217", 0, 0, "09000064803faa5f"], ["FDA-2008-N-0039-0016", "FDA", "FDA-2008-N-0039", "Implantation or Injectable Dosage Form New Animal Drugs; Change of Sponsor; Ferric Oxide Injection; Gleptoferron Injection; Iron Dextran Complex Injection; Iron Hydrogenated Dextran Injection", "Rule", "Final Rule", "2008-03-10T04:00:00Z", 2008, 3, "2008-03-10T04:00:00Z", null, "2013-07-11T14:40:49Z", "E8-04603", 0, 0, "09000064803ef1ac"], ["FDA-2008-N-0039-0015", "FDA", "FDA-2008-N-0039", "Intramammary Dosage Forms; Cephapirin Benzathine", "Rule", "Final Rule", "2008-03-07T05:00:00Z", 2008, 3, "2008-03-07T05:00:00Z", null, "2013-07-11T12:48:12Z", "E8-04473", 0, 0, "09000064803eace5"], ["FDA-2008-N-0039-0013", "FDA", "FDA-2008-N-0039", "New Animal Drugs; Albendazole", "Rule", "Final Rule", "2008-02-29T05:00:00Z", 2008, 2, null, null, "2013-07-11T12:43:54Z", "E8-03877", 0, 0, "09000064803d5031"], ["FDA-2008-N-0039-0014", "FDA", "FDA-2008-N-0039", "Freedom of Information Summary - [NADA-110-048-New Animal Drugs; Albendazole]", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2008-02-29T05:00:00Z", 2008, 2, null, null, "2011-06-11T16:27:26Z", null, 0, 0, "09000064803d58bf"], ["FDA-2008-N-0039-0012", "FDA", "FDA-2008-N-0039", "Freedom of Information Summary - [ANADA-200-202-Oral Dosage Form New Animal Drugs; Ivermectin Liquid]", "Supporting & Related Material", "Freedom of Information Summary", "2008-02-22T05:00:00Z", 2008, 2, null, null, "2013-07-10T15:45:54Z", null, 0, 0, "09000064803ba587"], ["FDA-2008-N-0039-0011", "FDA", "FDA-2008-N-0039", "Oral Dosage Form New Animal Drugs; Altrenogest", "Rule", "Final Rule", "2008-02-21T05:00:00Z", 2008, 2, "2008-02-21T05:00:00Z", null, "2013-07-11T12:41:07Z", "E8-03265", 0, 0, "09000064803b9f24"], ["FDA-2008-N-0039-0010", "FDA", "FDA-2008-N-0039", "Oral Dosage Form New Animal Drugs; Ivermectin Liquid", "Rule", "NFR-Notice of Final Rule", "2008-02-21T05:00:00Z", 2008, 2, "2008-02-21T05:00:00Z", null, "2013-07-10T15:41:57Z", "E8-03266", 0, 0, "09000064803b9f98"], ["FDA-2008-N-0039-0009", "FDA", "FDA-2008-N-0039", "New Animal Drugs; Change of Sponsor; Ketamine", "Rule", "Final Rule", "2008-02-13T05:00:00Z", 2008, 2, "2008-02-13T05:00:00Z", null, "2013-07-10T16:07:12Z", "E8-02607", 0, 0, "09000064803adb81"], ["FDA-2008-N-0039-0008", "FDA", "FDA-2008-N-0039", "Oral Dosage Form New Animal Drugs; Phenylbutazone Tablets", "Rule", "Final Rule", "2008-02-13T05:00:00Z", 2008, 2, "2008-02-13T05:00:00Z", null, "2013-07-11T13:04:52Z", "E8-02608", 0, 0, "09000064803adadb"], ["FDA-2008-N-0039-0007", "FDA", "FDA-2008-N-0039", "Oral Dosage Form New Animal Drugs: Spectinomycin", "Rule", "NFR-Notice of Final Rule", "2008-02-05T05:00:00Z", 2008, 2, null, null, "2008-04-11T22:39:13Z", "E8-02065", 0, 0, "09000064803a8563"], ["FDA-2008-N-0039-0004", "FDA", "FDA-2008-N-0039", "Freedom of Information Summary - [NADA-141-276-For Use in Animal Feed; Zilpaterol]", "Supporting & Related Material", "Freedom of Information Summary", "2008-02-01T05:00:00Z", 2008, 2, null, null, "2013-07-10T18:01:23Z", null, 0, 0, "09000064803a6603"], ["FDA-2008-N-0039-0006", "FDA", "FDA-2008-N-0039", "Freedom of Information Summary - [NADA-141-244-Implantation or Injectable Dosage Form New Animal Drugs; Tulathromycin]", "Supporting & Related Material", "Freedom of Information Summary", "2008-02-01T05:00:00Z", 2008, 2, null, null, "2013-07-10T18:37:53Z", null, 0, 0, "09000064803a66e8"], ["FDA-2008-N-0039-0005", "FDA", "FDA-2008-N-0039", "Implantation or Injectable Dosage Form New Animal Drugs; Tulathromycin", "Rule", "Final Rule", "2008-02-01T05:00:00Z", 2008, 2, "2008-02-01T05:00:00Z", null, "2013-07-10T18:34:59Z", "E8-01906", 0, 0, "09000064803a6488"], ["FDA-2008-N-0039-0003", "FDA", "FDA-2008-N-0039", "New Animal Drugs For Use in Animal Feed; Zilpaterol", "Rule", "Final Rule", "2008-02-01T05:00:00Z", 2008, 2, "2008-02-01T05:00:00Z", null, "2013-07-11T14:38:03Z", "E8-01903", 0, 0, "09000064803a642e"], ["FDA-2008-N-0039-0002", "FDA", "FDA-2008-N-0039", "Oral Dosage Form New Animal Drugs; Clindamycin", "Rule", "Final Rule", "2008-01-24T05:00:00Z", 2008, 1, "2008-01-24T05:00:00Z", null, "2013-07-09T20:13:31Z", "E8-01199", 0, 0, "09000064803a17e1"], ["FDA-2008-N-0039-0001", "FDA", "FDA-2008-N-0039", "Intramammary Dosage Forms; Cephapirin Sodium", "Rule", "Final Rule", "2008-01-17T05:00:00Z", 2008, 1, "2008-01-17T05:00:00Z", null, "2013-07-11T13:00:09Z", "E8-00816", 0, 0, "090000648039c6a6"]], "truncated": false, "filtered_table_rows_count": 98, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2008-N-0039"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0039", "results": [{"value": "FDA", "label": "FDA", "count": 98, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2008-N-0039", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0039", "results": [{"value": "Rule", "label": "Rule", "count": 54, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0039&document_type=Rule", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 39, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0039&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 5, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0039&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0039", "results": [{"value": 2008, "label": 2008, "count": 92, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0039&posted_year=2008", "selected": false}, {"value": 2009, "label": 2009, "count": 6, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0039&posted_year=2009", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0039&_facet=subtype"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0039&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0039&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0039&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0039&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0039&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 163.46594295464456, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}